Effect of dexmedetomidine on plasma brain-derived neurotrophic factor: A
double-blind, randomized and placebo-controlled study.
Author(s): Yang L(1), Xu JM, Jiang X, Ruan W, Cui Y, He L.
Affiliation(s): Author information:
(1)Department of Anesthesiology, The Second Xiangya Hospital, Central South
University and Anesthesiology Research Institute, Central South University ,
Changsha, Hunan , People's Republic of China.
Publication date & source: 2013, Ups J Med Sci. , 118(4):235-9
BACKGROUND: Dexmedetomidine (DEX) has neuro-protective effects, but the clinical
mechanism remains unclear.
METHOD: Forty patients were randomly divided into two groups: group A (control)
and group B (treated with DEX). Plasma concentrations of brain-derived
neurotrophic factor (BDNF) were determined in blood samples using enzyme-linked
immunosorbent assays at five time points: T1 (baseline), T2 (15 minutes after
intubation and before the surgery was started), T3 (the end of surgery), T4 (10
minutes after extubation in the post-anesthesia care unit), and T5 (24 hours
after the surgery). Changes in bispect (BIS) index, heart rates, and doses of
anesthetics used for induction were also recorded.
RESULTS: Baseline plasma concentrations of BDNF did not differ between group A
and group B; 15 minutes after induction, concentrations of plasma BDNF were
significantly reduced in group A. Twenty-four hours after surgery, the
concentration was still higher in group B than in group A. In contrast, plasma
concentrations of BDNF at other time points tested did not differ between the two
groups.
CONCLUSION: It appears that DEX could reverse the reduced plasma concentrations
of BDNF caused by anesthetics, and this effect lasted for 24 hours after surgery.
|